Cart
sales@molnova.com
P-SCN-Bn-DOTA
CAS No. 127985-74-4
P-SCN-Bn-DOTA( —— )
Catalog No. M35058 CAS No. 127985-74-4
p-SCN-Bn-DOTA is a chelator that simultaneously binds radionuclides and links monoclonal antibodies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 151 | In Stock |
|
| 5MG | 123 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 353 | In Stock |
|
| 50MG | 533 | In Stock |
|
| 100MG | 759 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameP-SCN-Bn-DOTA
-
NoteResearch use only, not for human use.
-
Brief Descriptionp-SCN-Bn-DOTA is a chelator that simultaneously binds radionuclides and links monoclonal antibodies.
-
Descriptionp-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunoresearch of tumor.
-
In Vitrop-SCN-Bn-DOTA is complexed with 5 different metal ions: In(III), Y(III), Lu(III), Gd(III) and Cu(II).
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number127985-74-4
-
Formula Weight551.61
-
Molecular FormulaC24H33N5O8S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20.83 mg/mL (37.76 mM; Ultrasonic (<60°C)
-
SMILESOC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)C(Cc2ccc(cc2)N=C=S)CN(CC(O)=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vera DRB, et, al. Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors. Cancer Biother Radiopharm. 2011 Jun;26(3):287-97.?
molnova catalog
related products
-
MSC2504877
MSC2504877 is an inhibitor of tankyrase and enhances the effects of clinical CDK4/6 inhibitors. MSC2504877 suppresses the upregulation of Cyclin D2 and Cyclin E2 caused by palbociclib and enhances the suppression of phospho-Rb.
-
UUN44923
UUN44923 is a FTO inhibitor.?It may be useful for treating diseases assocd.?with FTO targets, obesity, metabolic syndrome (MS) , type 2 diabetes (T2D) , Alzheimer's diseases, breast cancers, small- cell lung cancers, a human bone marrow striated muscle cancer, a pancreatic cancer, malignant glioblastoma and the like.?
-
Bisdemethoxycurcumin
Bisdemethoxycurcumin (BDMC) is a natural demethoxy derivative of curcumin.
